BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ardea Biosciences, Inc. 

4939 Directors Place

San Diego  California  92121  U.S.A.
Phone: 858-652-6500 Fax: 858-652-0760


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
AstraZeneca PLC (AZN) and Ardea Biosciences, Inc. Release: A Large, Observational Study of Common Gout Treatment Allopurinol Shows Less Than Half of Patients Reach Recommended Treatment Goal 10/28/2013 10:13:36 AM    More...
AstraZeneca PLC (AZN) Completes Acquisition of Ardea Biosciences, Inc. 6/20/2012 9:06:02 AM    More...
Ardea Biosciences, Inc. Announces Expiration of HSR Waiting Period in Connection With Proposed Merger 6/5/2012 9:14:03 AM    More...
Ardea Biosciences, Inc. Earns $7.5 Million Milestone From Bayer HealthCare (BAY) 5/30/2012 9:09:26 AM    More...
Ardea Biosciences, Inc. Announces First Quarter 2012 Financial Results 5/7/2012 8:40:10 AM    More...
Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. 4/25/2012 9:21:10 AM    More...
AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout 4/23/2012 6:58:00 AM    More...
Ardea Biosciences, Inc. Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2011 Financial Results 3/9/2012 8:31:19 AM    More...
Ardea Biosciences, Inc. to Present at Upcoming Investor Conferences 2/29/2012 9:23:41 AM    More...
Ardea Biosciences, Inc. to Present at Upcoming Investor Conferences 2/9/2012 8:45:07 AM    More...
12345678910...